
Sign up to save your podcasts
Or


Watch Scarlet and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.
Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu
-Anurag Rana, Bloomberg Intelligence Technology Analyst, discusses Nvidia, the dominant maker of artificial intelligence chips, investing an additional $2 billion in the cloud computing firm and key customer CoreWeave. He also discusses Microsoft rolling out its second-generation artificial intelligence chip, the Maia 200 chip, to power its services more efficiently and provide an alternative to Nvidia Corp. hardware.
-Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals Analyst, discusses the latest in the biotech sector. Merck & Co. is no longer in talks to acquire biotech firm Revolution Medicines Inc. after the two companies couldn’t agree on a price, the Wall Street Journal reported, citing people familiar with the matter.
-David Woo, Founder and Strategist at Unbound Retail, discusses his book: “Merry-Go-Round Broke Down: A Novel of Guilt, Greed & Globalization.” Set against pivotal moments from the late 1990s through the 2008 financial crisis, the novel follows interconnected characters including CEOs, financiers, factory owners, and workers whose lives collide as global capital reshapes industries and societies. It offers something rare: a way to talk about systemic risk, incentives, and unintended consequences through story, not abstraction.
See omnystudio.com/listener for privacy information.
By Bloomberg3.8
381381 ratings
Watch Scarlet and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.
Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu
-Anurag Rana, Bloomberg Intelligence Technology Analyst, discusses Nvidia, the dominant maker of artificial intelligence chips, investing an additional $2 billion in the cloud computing firm and key customer CoreWeave. He also discusses Microsoft rolling out its second-generation artificial intelligence chip, the Maia 200 chip, to power its services more efficiently and provide an alternative to Nvidia Corp. hardware.
-Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals Analyst, discusses the latest in the biotech sector. Merck & Co. is no longer in talks to acquire biotech firm Revolution Medicines Inc. after the two companies couldn’t agree on a price, the Wall Street Journal reported, citing people familiar with the matter.
-David Woo, Founder and Strategist at Unbound Retail, discusses his book: “Merry-Go-Round Broke Down: A Novel of Guilt, Greed & Globalization.” Set against pivotal moments from the late 1990s through the 2008 financial crisis, the novel follows interconnected characters including CEOs, financiers, factory owners, and workers whose lives collide as global capital reshapes industries and societies. It offers something rare: a way to talk about systemic risk, incentives, and unintended consequences through story, not abstraction.
See omnystudio.com/listener for privacy information.

973 Listeners

1,166 Listeners

2,184 Listeners

422 Listeners

973 Listeners

196 Listeners

1,038 Listeners

187 Listeners

68 Listeners

1,309 Listeners

65 Listeners

77 Listeners

30 Listeners

62 Listeners

5 Listeners

58 Listeners

233 Listeners

232 Listeners

68 Listeners

80 Listeners

78 Listeners

75 Listeners

86 Listeners

405 Listeners

18 Listeners

13 Listeners

7 Listeners

2 Listeners

115 Listeners

23 Listeners